Skip to content

Effects of different blood pressure management on postoperative complications in elderly patients undergoing intermediate-and high-risk surgery:a randomized controlled trial

Effects of different blood pressure management on postoperative complications in elderly patients undergoing intermediate-and high-risk surgery:a randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056219
Enrollment
Unknown
Registered
2022-02-01
Start date
2022-04-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative complications: postoperative acute kidney injury,myocardial injury after noncardiac surgery

Interventions

Absolute threshold group:The intraoperative MAP was maintained above 70mmHg
Relative threshold group:Intraoperative SBP was maintained above 80% of baseline

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adult patients were scheduled for an elective intermediate-to high-risk abdominal or orthopedic surgical procedure under general anesthesia; 2. Aged > 60 years; 3. ASA classification I-III; 4. Patients were scheduled for surgery with an expected duration of 2 hours or longer; 5. Agree to participate in the study, accept follow-up, and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients were excluded if they had severe uncontrolled hypertension(SBP>= 180mmHg or diastolic blood pressure >= 110mmHg); 2. Preoperative MAP 3; 5. Patients had acute or decompensated heart failure or acute coronary syndrome; 6. Severe arrhythmia and severe valvular disease; 7. Patients had preoperative sepsis or were already receiving norepinephrine infusion; 8. Patients had chronic kidney disease(glomerular filtration rate < 30mL/min/1.73m2 or requiring renal replacement therapy for end-stage renal disease); 9. Restricted infusion was required during the operation.

Design outcomes

Primary

MeasureTime frame
Incidence of acute kidney injury by day 7 after surgery;Incidence of myocardial injury by day 7 after surgery;All-cause mortality at 30 days after surgery;

Secondary

MeasureTime frame
Incidence of f systemic inflammatory response syndrome by day 7 after surgery;Adverse events of each system;Unplanned admission rate to ICU;Length of stay;

Countries

China

Contacts

Public ContactLiu Su

The Affiliated Hospital of Xuzhou Medical University

150040009@qq.com+86 18118309692

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026